MetaADEDB 2.0 @ LMMD
Eszopiclone
(GBBSUAFBMRNDJC-INIZCTEOSA-N)
Structure
SMILES
CN1CCN(CC1)C(=O)O[C@H]1c2nccnc2C(=O)N1c1ccc(cn1)Cl
Type(s)
Approved; Investigational
ATC code(s)
N05CF04
Molecular Formula:
C17H17ClN6O3
Molecular Weight:
388.808
Log P:
1.5088
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
0
TPSA:
91.76
CAS Number(s):
138729-47-2
Synonym(s)
1.
Eszopiclone
2.
Estorra
3.
Lunesta
External Link(s)
MeSHD000069582
PubChem Compound969472
BindingDB50247998
26265
ChEBI53760
CHEMBLCHEMBL1522
DrugBankDB00402
DrugCentral1068
IUPHAR/BPS Guide to PHARMACOLOGY7429
KEGGdr:D02624
Therapeutic Target DatabaseD06ZII
ZINC19632834
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DysgeusiaFAERS: 2194US FAERS
2Drug ineffectiveFAERS: 2127US FAERS
3Middle insomniaFAERS: 416US FAERS
4Initial insomniaFAERS: 300US FAERS
5SomnolenceFAERS: 217US FAERS
6HeadacheFAERS: 194US FAERS
7NauseaFAERS: 150US FAERS
8DizzinessFAERS: 104US FAERS
9Paradoxical drug reactionFAERS: 86US FAERS
10AmnesiaFAERS: 66US FAERS
11AnxietyFAERS: 64US FAERS
12FatigueFAERS: 58US FAERS
13VomitingFAERS: 56US FAERS
14Product substitution issueFAERS: 53US FAERS
15Feeling abnormalFAERS: 51US FAERS
16AgitationFAERS: 40US FAERS
17PruritusFAERS: 36US FAERS
18PalpitationsFAERS: 35US FAERS
19OverdoseFAERS: 31US FAERS
20MalaiseFAERS: 30US FAERS
21Memory impairmentFAERS: 28US FAERS
22NervousnessFAERS: 24US FAERS
23TremorFAERS: 24US FAERS
24Product quality issueFAERS: 23US FAERS
25Suicide attemptFAERS: 22US FAERS
26DyspepsiaFAERS: 20US FAERS
27SomnambulismFAERS: 19US FAERS
28DeliriumFAERS: 18US FAERS
29Abdominal PainFAERS: 17US FAERS
30DisorientationFAERS: 17US FAERS
31ParasomniaFAERS: 17US FAERS
32UrticariaFAERS: 17US FAERS
33Poor quality sleepFAERS: 16US FAERS
34RestlessnessFAERS: 16US FAERS
35AlopeciaFAERS: 15US FAERS
36Throat irritationFAERS: 15US FAERS
37Chest PainFAERS: 14US FAERS
38ConstipationFAERS: 14US FAERS
39PainFAERS: 14US FAERS
40Drug withdrawal syndromeFAERS: 13US FAERS
41Product taste abnormalFAERS: 13US FAERS
42AstheniaFAERS: 12US FAERS
43Weight decreasedFAERS: 12US FAERS
44TinnitusFAERS: 11US FAERS
45Abnormal sleep-related eventFAERS: 10US FAERS
46Completed SuicideFAERS: 10US FAERS
47HypersensitivityFAERS: 10US FAERS
48Incorrect dose administeredFAERS: 10US FAERS
49Pharmaceutical product complaintFAERS: 10US FAERS
50Rebound effectFAERS: 10US FAERS
51AnorexiaFAERS: 9US FAERS
52Chest discomfortFAERS: 9US FAERS
53Drug DependenceFAERS: 9US FAERS
54Feeling jitteryFAERS: 9US FAERS
55Pharyngolaryngeal PainFAERS: 9US FAERS
56RetchingFAERS: 9US FAERS
57Abdominal discomfortFAERS: 8US FAERS
58AgeusiaFAERS: 8US FAERS
59CryingFAERS: 8US FAERS
60FlatulenceFAERS: 8US FAERS
61LethargyFAERS: 8US FAERS
62MyalgiaFAERS: 8US FAERS
63Wrong technique in product usage processFAERS: 8US FAERS
64AngerFAERS: 7US FAERS
65ArthralgiaFAERS: 7US FAERS
66ChillsFAERS: 7US FAERS
67Drug ToleranceFAERS: 7US FAERS
68HypersomniaFAERS: 7US FAERS
69Impaired driving abilityFAERS: 7US FAERS
70Restless Legs SyndromeFAERS: 7US FAERS
71Back PainFAERS: 6US FAERS
72Burning sensationFAERS: 6US FAERS
73DehydrationFAERS: 6US FAERS
74Depressed Level of ConsciousnessFAERS: 6US FAERS
75DysphoniaFAERS: 6US FAERS
76Medication ErrorFAERS: 6US FAERS
77Respiratory DepressionFAERS: 6US FAERS
78VertigoFAERS: 6US FAERS
79Visual disturbanceFAERS: 6US FAERS
80Eye painFAERS: 5US FAERS
81Feeling ColdFAERS: 5US FAERS
82NasopharyngitisFAERS: 5US FAERS
83TachycardiaFAERS: 5US FAERS
84Therapeutic response unexpectedFAERS: 5US FAERS
85Accidental overdoseFAERS: 4US FAERS
86AcneFAERS: 4US FAERS
87Altered state of consciousnessFAERS: 4US FAERS
88Blood glucose increasedFAERS: 4US FAERS
89Drug effect delayedFAERS: 4US FAERS
90DysuriaFAERS: 4US FAERS
91Emotional disorderFAERS: 4US FAERS
92FlushingFAERS: 4US FAERS
93HostilityFAERS: 4US FAERS
94HungerFAERS: 4US FAERS
95HypotensionFAERS: 4US FAERS
96Intentional product use issueFAERS: 4US FAERS
97Renal painFAERS: 4US FAERS
98ScreamingFAERS: 4US FAERS
99Sleep-related eating disorderFAERS: 4US FAERS
100SluggishnessFAERS: 4US FAERS
101SneezingFAERS: 4US FAERS
102StomatitisFAERS: 4US FAERS
103StressFAERS: 4US FAERS
104Therapeutic response changedFAERS: 4US FAERS
105Adverse eventFAERS: 3US FAERS
106ApathyFAERS: 3US FAERS
107BruxismFAERS: 3US FAERS
108Depressed moodFAERS: 3US FAERS
109Drug dose omissionFAERS: 3US FAERS
110EructationFAERS: 3US FAERS
111ErythemaFAERS: 3US FAERS
112Euphoric moodFAERS: 3US FAERS
113Extra dose administeredFAERS: 3US FAERS
114Eye irritationFAERS: 3US FAERS
115FormicationFAERS: 3US FAERS
116Gastrointestinal PainFAERS: 3US FAERS
117GingivitisFAERS: 3US FAERS
118Impaired work abilityFAERS: 3US FAERS
119IncontinenceFAERS: 3US FAERS
120Joint swellingFAERS: 3US FAERS
121Mental impairmentFAERS: 3US FAERS
122Musculoskeletal chest painFAERS: 3US FAERS
123Musculoskeletal stiffnessFAERS: 3US FAERS
124ParanoiaFAERS: 3US FAERS
125PhotophobiaFAERS: 3US FAERS
126Physical assaultFAERS: 3US FAERS
127PoisoningFAERS: 3US FAERS
128Product physical issueFAERS: 3US FAERS
129Skin lacerationFAERS: 3US FAERS
130SwellingFAERS: 3US FAERS
131TensionFAERS: 3US FAERS
132Unevaluable eventFAERS: 3US FAERS
133Wrong technique in drug usage processFAERS: 3US FAERS
134AnorgasmiaFAERS: 2US FAERS
135ArthritisFAERS: 2US FAERS
136Atrial FibrillationFAERS: 2US FAERS
137Cerebrovascular accidentFAERS: 2US FAERS
138ConjunctivitisFAERS: 2US FAERS
139DependenceFAERS: 2US FAERS
140DiscomfortFAERS: 2US FAERS
141DissociationFAERS: 2US FAERS
142Drug administration errorFAERS: 2US FAERS
143Drug effect incompleteFAERS: 2US FAERS
144Drug effect variableFAERS: 2US FAERS
145Drug exposure during pregnancyFAERS: 2US FAERS
146Dry skinFAERS: 2US FAERS
147DyscheziaFAERS: 2US FAERS
148Ear discomfortFAERS: 2US FAERS
149Emotional distressFAERS: 2US FAERS
150Erectile dysfunctionFAERS: 2US FAERS
151GoutFAERS: 2US FAERS
152HomicideFAERS: 2US FAERS
153HypotrichosisFAERS: 2US FAERS
154HysterectomyFAERS: 2US FAERS
155Inappropriate affectFAERS: 2US FAERS
156IncoherentFAERS: 2US FAERS
157Limb discomfortFAERS: 2US FAERS
158MenorrhagiaFAERS: 2US FAERS
159Mental status changesFAERS: 2US FAERS
160Mood swingsFAERS: 2US FAERS
161Musculoskeletal PainFAERS: 2US FAERS
162Myocardial InfarctionFAERS: 2US FAERS
163MyoclonusFAERS: 2US FAERS
164Non-cardiac chest painFAERS: 2US FAERS
165PneumoniaFAERS: 2US FAERS
166PolyuriaFAERS: 2US FAERS
167Postoperative deliriumFAERS: 2US FAERS
168Prescribed overdoseFAERS: 2US FAERS
169Product coating issueFAERS: 2US FAERS
170Rash erythematousFAERS: 2US FAERS
171Respiratory arrestFAERS: 2US FAERS
172Sleep TalkingFAERS: 2US FAERS
173StuporFAERS: 2US FAERS
174Thermal burnFAERS: 2US FAERS
175ThirstFAERS: 2US FAERS
176ThrombosisFAERS: 2US FAERS
177Traumatic Brain InjuryFAERS: 2US FAERS
178Urinary IncontinenceFAERS: 2US FAERS
179Urinary tract infectionFAERS: 2US FAERS
180AbasiaFAERS: 1US FAERS
181Accidental drug intake by childFAERS: 1US FAERS
182Accidental exposure to productFAERS: 1US FAERS
183Activities of daily living impairedFAERS: 1US FAERS
184Alanine Aminotransferase IncreasedFAERS: 1US FAERS
185Allergy to chemicalsFAERS: 1US FAERS
186Ammonia increasedFAERS: 1US FAERS
187Angina PectorisFAERS: 1US FAERS
188AnosmiaFAERS: 1US FAERS
189AphasiaFAERS: 1US FAERS
190AphoniaFAERS: 1US FAERS
191Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
192AsthmaFAERS: 1US FAERS
193Back disorderFAERS: 1US FAERS
194BedriddenFAERS: 1US FAERS
195BelligerenceFAERS: 1US FAERS
196Bipolar DisorderFAERS: 1US FAERS
197Bladder discomfortFAERS: 1US FAERS
198BlepharospasmFAERS: 1US FAERS
199Blood alkaline phosphatase increasedFAERS: 1US FAERS
200Blood creatinine increasedFAERS: 1US FAERS
201Blood testosterone decreasedFAERS: 1US FAERS
202Blood urea increasedFAERS: 1US FAERS
203Blunted affectFAERS: 1US FAERS
204Breast tendernessFAERS: 1US FAERS
205BursitisFAERS: 1US FAERS
206Carbon Monoxide PoisoningFAERS: 1US FAERS
207Carbon dioxide increasedFAERS: 1US FAERS
208CellulitisFAERS: 1US FAERS
209Cerebral disorderFAERS: 1US FAERS
210Choking sensationFAERS: 1US FAERS
211CholelithiasisFAERS: 1US FAERS
212Cold sweatFAERS: 1US FAERS
213Contraindicated drug administeredFAERS: 1US FAERS
214Conversion disorderFAERS: 1US FAERS
215CystitisFAERS: 1US FAERS
216Dental discomfortFAERS: 1US FAERS
217DiverticulitisFAERS: 1US FAERS
218Dreamy stateFAERS: 1US FAERS
219DrowningFAERS: 1US FAERS
220Drug abuserFAERS: 1US FAERS
221Drug dispensing errorFAERS: 1US FAERS
222Drug exposure via breast milkFAERS: 1US FAERS
223Drug prescribing errorFAERS: 1US FAERS
224Drug screen negativeFAERS: 1US FAERS
225DysarthriaFAERS: 1US FAERS
226Electrocardiogram QT interval abnormalFAERS: 1US FAERS
227Electrocardiogram abnormalFAERS: 1US FAERS
228EnuresisFAERS: 1US FAERS
229Eyelid dermatochalasisFAERS: 1US FAERS
230FibromyalgiaFAERS: 1US FAERS
231FibrosisFAERS: 1US FAERS
232Flank PainFAERS: 1US FAERS
233Food PoisoningFAERS: 1US FAERS
234FrustrationFAERS: 1US FAERS
235Gas PoisoningFAERS: 1US FAERS
236GlossitisFAERS: 1US FAERS
237Hallucinations, mixedFAERS: 1US FAERS
238HyperacusisFAERS: 1US FAERS
239HyperkinesiaFAERS: 1US FAERS
240HypermetabolismFAERS: 1US FAERS
241HypokinesiaFAERS: 1US FAERS
242HypoxiaFAERS: 1US FAERS
243Iatrogenic infectionFAERS: 1US FAERS
244Inappropriate schedule of drug administrationFAERS: 1US FAERS
245Increased upper airway secretionFAERS: 1US FAERS
246InfectionFAERS: 1US FAERS
247InfluenzaFAERS: 1US FAERS
248Infrequent bowel movementsFAERS: 1US FAERS
249Intentional drug misuseFAERS: 1US FAERS
250Intentional misuseFAERS: 1US FAERS
251Intentional product misuseFAERS: 1US FAERS
252Intentional self-injuryFAERS: 1US FAERS
253Joint stiffnessFAERS: 1US FAERS
254KetonuriaFAERS: 1US FAERS
255Lip swellingFAERS: 1US FAERS
256Lower respiratory tract infectionFAERS: 1US FAERS
257Malignant melanoma stage IIIFAERS: 1US FAERS
258MastitisFAERS: 1US FAERS
259Metabolic acidosisFAERS: 1US FAERS
260Micturition frequency decreasedFAERS: 1US FAERS
261Morbid thoughtsFAERS: 1US FAERS
262Motion SicknessFAERS: 1US FAERS
263Multiple drug overdoseFAERS: 1US FAERS
264Myasthenic SyndromeFAERS: 1US FAERS
265Nasal discomfortFAERS: 1US FAERS
266Neck PainFAERS: 1US FAERS
267No adverse eventFAERS: 1US FAERS
268NocturiaFAERS: 1US FAERS
269Nonspecific reactionFAERS: 1US FAERS
270NystagmusFAERS: 1US FAERS
271Obsessive-Compulsive DisorderFAERS: 1US FAERS
272Oral painFAERS: 1US FAERS
273Oropharyngeal painFAERS: 1US FAERS
274PO2 decreasedFAERS: 1US FAERS
275PallorFAERS: 1US FAERS
276Pancreatic enlargementFAERS: 1US FAERS
277PancreatitisFAERS: 1US FAERS
278Panic DisorderFAERS: 1US FAERS
279Paraesthesia of genital maleFAERS: 1US FAERS
280Partner stressFAERS: 1US FAERS
281Pelvic discomfortFAERS: 1US FAERS
282Personality ChangeFAERS: 1US FAERS
283PharyngitisFAERS: 1US FAERS
284Poor quality drug administeredFAERS: 1US FAERS
285Prescription drug used without a prescriptionFAERS: 1US FAERS
286PresyncopeFAERS: 1US FAERS
287PriapismFAERS: 1US FAERS
288Product comminglingFAERS: 1US FAERS
289Product formulation issueFAERS: 1US FAERS
290Product size issueFAERS: 1US FAERS
291Product solubility abnormalFAERS: 1US FAERS
292Product use complaintFAERS: 1US FAERS
293Product use issueFAERS: 1US FAERS
294Psychomotor skills impairedFAERS: 1US FAERS
295Reaction to drug excipientsFAERS: 1US FAERS
296Respiratory FailureFAERS: 1US FAERS
297Respiratory distressFAERS: 1US FAERS
298Respiratory fume inhalation disorderFAERS: 1US FAERS
299Respiratory tract congestionFAERS: 1US FAERS
300Retinal migraineFAERS: 1US FAERS
301Retrograde amnesiaFAERS: 1US FAERS
302RhabdomyolysisFAERS: 1US FAERS
303Sexual DysfunctionFAERS: 1US FAERS
304Similar reaction on previous exposure to drugFAERS: 1US FAERS
305Sinus headacheFAERS: 1US FAERS
306SinusitisFAERS: 1US FAERS
307Sleep ParalysisFAERS: 1US FAERS
308Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
309SnoringFAERS: 1US FAERS
310Solar urticariaFAERS: 1US FAERS
311Sudden onset of sleepFAERS: 1US FAERS
312SunburnFAERS: 1US FAERS
313SyncopeFAERS: 1US FAERS
314Temperature intoleranceFAERS: 1US FAERS
315Therapeutic product effect incompleteFAERS: 1US FAERS
316Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
317Throat cancerFAERS: 1US FAERS
318Tongue blisteringFAERS: 1US FAERS
319Toxic Epidermal NecrolysisFAERS: 1US FAERS
320Urticaria localisedFAERS: 1US FAERS
321Ventricular hypertrophyFAERS: 1US FAERS
322Viral upper respiratory tract infectionFAERS: 1US FAERS
323Visual ImpairmentFAERS: 1US FAERS
324Vitreous floatersFAERS: 1US FAERS
325YawningFAERS: 1US FAERS
326Zinc deficiencyFAERS: 1US FAERS
327jaundiceFAERS: 1US FAERS
328muscle injuryFAERS: 1US FAERS
329nervous system disorderFAERS: 1US FAERS
330treatment failureFAERS: 1US FAERS
331Drug Overdose17606111CTD
332Sleep Initiation and Maintenance Disorders17557453CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.